APG Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-5,379
Closed -$717K – 563
2024
Q3
$717K Sell
5,379
-21,994
-80% -$3.15M ﹤0.01% 380
2024
Q2
$3.22M Buy
27,373
+11,333
+71% +$1.78M 0.01% 499
2024
Q1
$2.73M Sell
16,040
-23,917
-60% -$4.55M ﹤0.01% 506
2023
Q4
$6.5M Sell
39,957
-2,794
-7% -$435K 0.01% 453
2023
Q3
$6.8M Sell
42,751
-4,706
-10% -$769K 0.01% 447
2023
Q2
$6.15M Buy
47,457
+275
+0.6% +$44.1K 0.01% 458
2023
Q1
$7.31M Sell
47,182
-7,541
-14% -$1.35M 0.02% 449
2022
Q4
$9.27M Buy
+54,723
New +$9.93M 0.02% 458

Other funds holding RGEN

APG Asset Management's RGEN Position: Q4 2024 in Review

APG Asset Management sold out of Repligen (RGEN) in Q4 2024, closing a stake of 5,379 shares — an estimated $717K sold.

APG Asset Management first reported a position in RGEN in Q4 2022 and held it in 8 quarters. The position peaked at $9.27M in Q4 2022. 431 funds tracked by Wall St. Rank hold RGEN as of Q4 2024.

  • APG Asset Management reported no remaining Repligen position as of Q4 2024 after selling out during the quarter.
  • APG Asset Management sold 5,379 Repligen shares in Q4 2024, an estimated $717K.
  • APG Asset Management first reported a position in Repligen in Q4 2022 and held it in 8 quarters.
  • APG Asset Management's Repligen position peaked at $9.27M in Q4 2022.
  • 431 funds tracked by Wall St. Rank held Repligen as of Q4 2024.

Based on APG Asset Management's 13F filing for Q4 2024, filed 13 Feb 2025.